1. Home
  2. SRPT vs CENTA Comparison

SRPT vs CENTA Comparison

Compare SRPT & CENTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SRPT
  • CENTA
  • Stock Information
  • Founded
  • SRPT 1980
  • CENTA 1955
  • Country
  • SRPT United States
  • CENTA United States
  • Employees
  • SRPT N/A
  • CENTA N/A
  • Industry
  • SRPT Biotechnology: Pharmaceutical Preparations
  • CENTA Consumer Specialties
  • Sector
  • SRPT Health Care
  • CENTA Consumer Discretionary
  • Exchange
  • SRPT Nasdaq
  • CENTA Nasdaq
  • Market Cap
  • SRPT 1.9B
  • CENTA 1.8B
  • IPO Year
  • SRPT 1997
  • CENTA 1993
  • Fundamental
  • Price
  • SRPT $17.65
  • CENTA $28.33
  • Analyst Decision
  • SRPT Hold
  • CENTA Buy
  • Analyst Count
  • SRPT 30
  • CENTA 4
  • Target Price
  • SRPT $35.93
  • CENTA $36.67
  • AVG Volume (30 Days)
  • SRPT 6.1M
  • CENTA 365.4K
  • Earning Date
  • SRPT 11-03-2025
  • CENTA 11-24-2025
  • Dividend Yield
  • SRPT N/A
  • CENTA N/A
  • EPS Growth
  • SRPT N/A
  • CENTA N/A
  • EPS
  • SRPT N/A
  • CENTA 2.14
  • Revenue
  • SRPT $2,413,715,000.00
  • CENTA $3,120,375,000.00
  • Revenue This Year
  • SRPT $10.20
  • CENTA N/A
  • Revenue Next Year
  • SRPT N/A
  • CENTA $0.16
  • P/E Ratio
  • SRPT N/A
  • CENTA $13.13
  • Revenue Growth
  • SRPT 47.15
  • CENTA N/A
  • 52 Week Low
  • SRPT $10.42
  • CENTA $25.97
  • 52 Week High
  • SRPT $138.81
  • CENTA $37.35
  • Technical
  • Relative Strength Index (RSI)
  • SRPT 38.30
  • CENTA 46.37
  • Support Level
  • SRPT $15.08
  • CENTA $27.62
  • Resistance Level
  • SRPT $18.80
  • CENTA $29.58
  • Average True Range (ATR)
  • SRPT 1.40
  • CENTA 0.66
  • MACD
  • SRPT -0.84
  • CENTA 0.14
  • Stochastic Oscillator
  • SRPT 24.92
  • CENTA 40.77

About SRPT Sarepta Therapeutics Inc. (DE)

Sarepta Therapeutics Inc is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Majority of company's product candidates are at an early stage of development.

About CENTA Central Garden & Pet Company Nonvoting

Central Garden & Pet Co understands that home is central to life and has nurtured happy and healthy homes for over forty years. The segments of the company are the pet segment and garden segment. The company's trusted products are dedicated to helping lawns grow greener, gardens bloom bigger, pets live healthier and communities grow stronger. Central is home to a portfolio of more than sixty-five brands including Pennington, Nylabone, Kaytee, Amdro, and Aqueon, manufacturing and distribution capabilities, and a passionate, entrepreneurial growth culture. Central Garden and Pet is based in Walnut Creek, California, and has offices across North America and Europe.

Share on Social Networks: